Anteotech Ltd
ASX:ADO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Anteotech Ltd
Other Current Assets
Anteotech Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Anteotech Ltd
ASX:ADO
|
Other Current Assets
AU$135.1k
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
7%
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Other Current Assets
AU$588.1k
|
CAGR 3-Years
24%
|
CAGR 5-Years
28%
|
CAGR 10-Years
7%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Other Current Assets
AU$98.2k
|
CAGR 3-Years
4%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Other Current Assets
AU$2.2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Other Current Assets
AU$1.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
23%
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Other Current Assets
AU$5.2m
|
CAGR 3-Years
79%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
Anteotech Ltd
Glance View
AnteoTech Ltd. is a global nano-technology company, which develops, manufactures, and distributes products for the life sciences, clinical diagnostics and bio-separations markets. The company is headquartered in Eight Mile Plains, Queensland. The company went IPO on 2000-04-11. The firm is focused on the development and commercialization of its intellectual property of specialized surfaces used in the life sciences, diagnostics, energy and medical devices markets. The firm's products include AnteoCoat, AnteoBind and AnteoRelease, which are used in the energy, diagnostic and medical device markets. The firm's AnteoBind is an aqueous nanosized molecular glue (polymeric metal ions) used in a single-step process to facilitate multivalent coordination to bind carbohydrate polymers, antibodies, and proteins to synthetic substrates in assay development. The firm is also developing, SARS-CoV-2 Ag rapid test, which is a single-use, disposable, lateral flow test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal specimens collected from individuals who are suspected of COVID-19 infection.
See Also
What is Anteotech Ltd's Other Current Assets?
Other Current Assets
135.1k
AUD
Based on the financial report for Dec 31, 2025, Anteotech Ltd's Other Current Assets amounts to 135.1k AUD.
What is Anteotech Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
7%
Over the last year, the Other Current Assets growth was -40%. The average annual Other Current Assets growth rates for Anteotech Ltd have been -9% over the past three years , and 7% over the past ten years .
